18F-fluciclovine (Axumin) PET/CT detecting occult bone metastasis
Abstract Background 18F-fluciclovine (Axumin) positron emission tomography (PET) is a novel agent for detection of biochemical recurrence of the prostate cancer. In this article, we present an interesting case of prostate cancer recurrence with bone metastasis not visualized with conventional CT, bu...
Main Authors: | Pankaj Nepal, Paul Rodrigue, Thomas Olsavsky |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2020-07-01
|
Series: | The Egyptian Journal of Radiology and Nuclear Medicine |
Online Access: | http://link.springer.com/article/10.1186/s43055-020-00267-2 |
Similar Items
-
Detection of Recurrent Prostate Cancer With 18F-Fluciclovine PET/MRI
by: Kirsten Margrete Selnæs, et al.
Published: (2020-12-01) -
Diagnostic accuracy of 18F-Fluciclovine PET/CT in primary lymph node staging of prostate cancer
by: R.J. Hoekstra, et al.
Published: (2020-11-01) -
Cancer imaging with fluciclovine (18F)
by: Teoh, Eugene
Published: (2018) -
The Diagnostic Role of 18F-Choline, 18F-Fluciclovine and 18F-PSMA PET/CT in the Detection of Prostate Cancer With Biochemical Recurrence: A Meta-Analysis
by: Rang Wang, et al.
Published: (2021-06-01) -
[18F]Fluciclovine PET discrimination between high- and low-grade gliomas
by: Ephraim E. Parent, et al.
Published: (2018-07-01)